NCT03460457View on ClinicalTrials.gov

Tolerance and Pharmacokinetics of TQB2450

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Tumor
Interventions
DRUG

TQB2450

Pharmacokinetics/Dynamics Study

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY